The Effects of Parathyroid Extract on Renal
Function in Man
Howard H. Hiatt, David D. Thompson
J Clin Invest. 1957;36(4):557-565. https://doi.org/10.1172/JCI103454.
Research Article
Find the latest version:
THE EFFECTS OF PARATHYROID EXTRACT ON RENAL FUNCTION IN MAN
By HOWARD H. HIATT 1 AND DAVID D. THOMPSON 2
(From theNational Instituteof ArthritisandMetabolic Diseases, National Institutes ofHealth, Public HealthService,U. S.Department of Health,Education and Welfare, Bethesda, Md.)
(Submitted forpublication August 30, 1956; accepted December 13, 1956)
The evidence that parathyroid extract acts di-rectly onbone appearsconclusive(1-3). Whether the extract exerts an effect on the kidney, how-ever, has not been so convincingly answered. It
has long been known that an increase in urinary
phosphate follows the administration of
parathy-roid extract (4, 5), but the mechanism of the phosphaturia has not been clearly elucidated.
Although the osteoclastic action of parathyroid
hormone could effect an increase in urinary inor-ganic phosphate, it could not simultaneously pro-duce the hypophosphatemia observed in patients
withhyperparathyroidism. Inhibition by the hor-moneoftherenalmechanism for conserving
phos-phate, on the other hand, would account for both
arise inurinaryand a fall inplasmaphosphate. Our studies demonstrate that a
depression
of the maximal renal tubular reabsorptive capacityfor phosphate follows the administration of
para-thyroid extract, although in normal subjects pro-longed treatment is required before such an effect is demonstrable.
SUBJECTS AND METHODS
Forty studies were carried out in nine of the normal subjects, the three patients with post-thyroidectomy hy-poparathyroidism and the hyperparathyroid male de-scribed in the previous paper (6). The experimental procedures have been outlined (6).3 All of the experi-ments were performed with the patients in the post-absorptive state.
Four lots of commercial (Eli Lilly & Company) para-thyroid extract were used. Each lot was shown to be
1Present address: Department of Medicine, Harvard
Medical School and Beth Israel Hospital, Boston, Mass. 2Present address: Department of Physiology, Cornell Medical College, New York, N. Y.
8The following abbreviations will be employed: GFR, glomerular filtration rate; RPF, effective renal plasma flow; CG., inulin clearance; CPAH, para-amino-hippurate clearance; Tm, maximal renal tubular transport rate; PTH, parathyroid extract; Ca, calcium; P, inorganic phosphate.
effective as demonstrated by a rise in serum Ca in at least one subject. Dosage is expressed in U.S.P. units, as assayed by the manufacturer. When given intrave-nously the hormone was usually administered over a periodof 4 to 8 minutes. For the more prolonged stud-ies it was given subcutaneously at 6 to 12 hourly in-tervals, except where otherwise indicated.
Tostudy theeffects of PTH onTmP,buffered sodium phosphate, pH 7.40,was infused until conditions ofrenal tubular saturation were assured. Simultaneous with the intravenous administration of PTH a sustaining in-fusion was begun containing, in addition to inulin and PAH, an amount of sodium phosphate calculated to maintain as constant as possible the elevated plasma P level. Thus, observations of the influence of PTH on TmP were permitted without the possible interference of rapidly changing plasma levels.
RESULTS
Acute
effects of intravenous parathyroid extract at
endogenous levels of plasma P
A rise in urinary phosphate occurred immedi-ately following the intravenous administration of 200 to 1,000 units of PTH both to normal (Figure 1) and to hypoparathyroid (Figure 2) subjects. Atypical study in a normal subject is outlined in Table I, while data from studies in three normal
subjects are summarized in Table II. In two of thenormalindividuals,C. H., and J. N., the rise in
urinaryP occurred as a result of an increase in fil-tered
P,
which in turn, was caused by an increase in GFR. Phosphate reabsorption was increased in one subject and unchanged in the other. In thethirdnormal individual, E. E., theincrease inexcreted P could be accounted for by a decrease in tubular reabsorption of P (Table II). No
changein serumcalcium wasobserved during the
2 to 4hoursfollowing the administration of PTH.
Flushing frequently followed the intravenous ad-ministration of PTH, and transient headache was an occasional complaint. A mild and brief
tachy-cardia often occurred, butno changes in tempera-tureorblood pressure wereobserved. There was
HOWARD H. HIATT AND DAVID D. THOMPSON
.0 200UNITSgv
o
T
L 0.5
C')
0
>- 0.25
4
z
7AM 8 9 10 II 12 1PM 2 PM
TIME
FIG. 1. URINARY PHOSPHATE EXCRETION BEFORE AND FoLLowING THE INTRAVENOUS ADMINISTRATION OF 200 UNITS OF PARATHYROID EXTRACT TO R. H., A 24-YEAR-OLD NORMAL FEMALE
no evidence of sensitization or
resistance,
even insubjects who received several injections over a
period oftwelve months.
Acute effects of intravenous parathyroid extract
under conditions of phosphate loading
Aswas noted atendogenous plasmaP
levels,
noconstant change in renal tubular
reabsorption
of Presultedfrom theadministration
ofPTH tosub-jects receivingPinfusions (Table III). Ifin the
study summarized in Table III one selects two
periods with comparable levels of plasma P, e.g.,
the 6th, before the administration of PTH, and the7th, after PTHwas
given,
onenotes thatafterPTH the excretion of P is
increased.
The riseinurinaryPis ascribableto anincrease infiltered P, the reabsorbed P
remaining
unchanged.
Similarfindings werenoted in ninestudies in five normal
subjects (Table IV). The levels of TmP
fol-lowing the administration of PTH did not differ
significantly
from those seen priorto theadminis-tration of the hormone
(Figure 3).
D.F.,
whoshowed the greatest fall in TmP
following
PTH,1.0 0
I
E
IL0.
0
IL
z
7AM 8 9 10 II 12 1PM
TIME
FIG. 2. URINARY PHOSPHATE EXCRETION BEFORE AND
FOLLOWING THE INTRAVENOUS ADMINISTRATION OF 200 UNITS OF PARATHYROID EXTRACT To L. D., A 52-YEAR-0uD FEMALE WITH POST-OPERATIVE.
HYPOPARATHYROID-was
unique
among thesubjects
studied in thatspontaneous variationsof his TmP ofsimilar mag-nitudewere observed onoccasions when no medi-cation was
given.
With but one exception a rise in GFR followed the intravenous administrationof
PTH,
andonall occasions astriking
rise inre-nal
plasma
flow was observed(Table
IV).
Inalmost all normal
subjects
the rise in GFR wasadequate
to account for the observed increase in Pexcretion.In the
hypoparathyroid
subjects,
on the otherhand,
the rise inurinary
P which followed theadministration of PTH resulted notonly from an
increase in filtered
P,
but from a striking dimi-nution in the reabsorbed Paswell(Table
V). A fall inTmP wasseenin all threehypoparathyroid
subjects, although
in A. W. a negligible decrease inresponseto PTHwasobserved on oneoccasionTABLE I
EFFECTS OF INTRAVENOUS PARATHYROID EXTRACT ON RENAL FUNCTION
AT ENDOGENOUS PLASM PHOSPHATE LEVELS
ELAPSED CPAll CIN PLASMA P PHOSPHATE
TIME Ii.
/m".1
F&M/mi. FILTERED EXCRETED REABSORBEDMin. FM/mi.. FM/mi.. IM/iaS.
82-106 S35 122 1.01 123 8 1 S
106-123 SI 106 1.04 113 7 106
123-152 458 106 1.03 109 6 103
152-189 83 138 1.00 138 20 118
189-217 825 130 0.96 125 24 101
J.N., 22yewoldnormal male.
Sustaining inlisinfusionbegunat 51mnl.
1SS-160.1.,1000USP waits ofparathyroidextract i.v.
TABLE II
ACUTE EFFECTS OF INTRAVENOUS PARATHYROID EXTRACT AT ENDOGENOUS PLASMA PHOSPHATE LEVELS IN NORMAL INDIVIDUALS
Units CPAH CIN Plasma P PhlsplseveM/i
Sublet ef ml/miu. ml/min. AM/mi Filtered EzSie Reabsrbed Extroct Before After Before After Before Ahf Before After Before After Befoe Aher
C.N. 800 550 674 121 145 1.12 127 136 184 2 1S 134 169
E.E. 800 620 930 130 131 1.08 1.06 140 139 3 18 137 121
J.N. 1000 502 832 112 134 1.03 0.98 115 131 7 22 106 109
TABLE III
EFFECTS OF INTRAVENOUS PARATHYROID EXTRACT ON RENAL FUNCTION DURING PHOSPHATE LOADING
lElpsed Urn
CPAH
CIN
PPl@a Phosphate PAI/min. 1|iambldi:__
Time | Flow | Pml/in
mI/min.
mi/mi..
UIM/mI
Fitrd Ecetd Rasre 0 lusli, PAH infusion bequn.1 41- 59 5.45 538 142 1.09 155 4 151
2 59- 75 1 8.00 I 500 135 1.07 144 4 140
76 Inulin, PAH, buffered sodium phosphate infusion begun.
3
109-139
L890
543 140 2.16 302 92 2104 139-170 5.00 502 142 2.52 358 152 206
5 201 -221 4.85 463 130 3.53 459 262 197
6 221-243 3.18 500 141 4.02 566 329 237
24 Maintenance inulil, PAH, phosphate infusion
he"un.
1247-251 200 USP wnitsof parwhroid extracti.v.7 279 -301 j3.45 652 152 4.15 625 386 239
HOWARD H. HIATT AND DAVID D. THOMPSON
Tic'L Itr
ACUTE EFFECTS OF INTRAVEOUS PARiTiYWROIDIETRACT ON INAL FUNCTION IN NORMALSUBJECTS
Units C__CPAN C~IN TaP
Dot Sojebe of A Aftr Penatm Sewp Aftr. Pumtl Afts. Prese
___4Emtel/wi.vJ~mb~i/wi.. ml/min. Chm. M/Nd. p.M_/r. C.has
3/25/54 C.M. 200, 16. 6O.v i1n 104 .0 190 215 +13 4/ 6/54 C. H. 200 500 620 + 4 1'6 146 + 7 217 241 + 11
7/1t3/54 C.L Soo 761 865 "4. 1 151 164 '4 9 138 14 + S
9/ 7/54 C.L' 500 56 610 b 44 13S 14 + 10 2X9 204 is
5/2S/54 E.L 900 62? 104 +6? 13S 15S* +13 l9 20 +23
6/10/54 .N 1000 475 M +S3 106 118 +11 177 15 11
6/22/54 LN. 1000 124 137 X10 176 16 + s
3/11/5U L. . 500 3W 6n 60 91 99 9 62 59 -.26
3/31/55 EP. SO0 S m41 + 96 118 + 99 12V +26
normal subjects occurred patients (Table VI).
The acute administrati cernible immediate effect potassium or on urinary
subjects.
Effects of prolonged trei extract
Hyperparathyroidism N
mal subjects on six occa
parathyroid patients by 1,800to4,500 units of e)
to 120 hours. In all sut
pophosphatemia, and an
cium and phosphate were Two subjects complainer
anorexia, polydipsia, pol
-.z250 7200
z 0 o
F-150
w100
w
50
C0 0
MINUTES
FIG. 3. VARIATIONS IN I jECTS BEFORE AND FoLLow] MINISTRATION OF PARATHYR
I in the hypoparathyroid These symptoms, as' well as the chemical
abnor-malities rapidly disappeared after discontinuation ion of PTH had no dis- of the hormone.
t on plasma calcium 'or The hyperparathyroid state was characterized
r calcium in any of the by a depression'of TmP in-'both normal (Table
VIII) and hypoparathyroid (Table IX)
sub-jects. The fall in TmP ranged from 27 to 64per
atment with parathyroid cent below control levels (Table
X)'.
In W. R.on one occasion (5/6/55) the TmP was reduced
was induced in five nor- byparathyroid extract to the level observed in the
Lsions and in two
hypo-
only patient with spontaneous hyperparathyroid-the administration of ismstudied. The latter, a72-year-oldmale with atract over periods of60 plasma Ca of 14.05 mg. per 100 ml. and a plasma
)jects hypercalcemia, hy- Pof0.53 AMper ml. wasfound to have a TmP of increase in urinaryrcal, 26E*M per minute.
e observed (Table VII). The effect of the prolonged administration of d of mild skeletal :pain, parathyroid extract on C1,, and on CPAH, in con-Iyuria, and constipation. trasttotheresults in the acute studies, was
incon-stant (Table X).
Renal function studies were carried out in a
THYROIDEXTRACTim. Ihypoparathyroid patient in the untreated state
(plasma Ca, 7.10 mg. per cent; P, 1.42 b&M per
ml.), in an "isoparathyroid" state, following the dailyadministration of 100 units of extract for 5
days (plasma Ca, 10.05;P, 1.10), and ina
hyper-i_< - - parathyroid state, following the daily
adminis-SUB(2JCT0)S
tration of 900 units of extractfor 3days (plasma
~.-4E.E(9
Otratio
of 90
&*E.EMOO
Ca,
1290;
P0.68)o
.Average
TmP
values of
-*0D.(500 ) 170, 15Q and
70&uM
perminute, respectively,werefound at these times (Figure 5). In a similar
I U
Z
series of studiesin a secondhypoparathyroid
sub-30 W0 1t0
ject, B. C., a
progressive
towering of TmP with'mP IN FIVa NoRMAL SUB-
increasing
doses of extract wasagain
notedING THE INTRAVENOUS AD (TableXI). Ofinterestisthe fact that 100 units
0om EXTRACT of parathyroid extract daily for 3 days served to
I
_PARA
I_
-9_ 60 30 0
560
EFFECTS OF PARATHYROD ON RENAL FUNCTION
TABLE V
ACUTE EFFECTS OF PARATHYROID EXTRACT ON RENAL FUNCTION IN HYPOPARATHYROIDISM
ELAPSED PHOSPHATE
TIME CPAH CIN PLASMA P FILTERED EXCRETED REABSORBED
MIN. ml/mi/mn. m/.m1n. PiM/Ml
N/in.
IN/min.
IN/mI.
77-. 97 345 90.0 2.26 181 79 102
97-116 316 73.0 2.60 190 96 94
116-136 315 75.5 3.00 226 116 110
159-192 711 840 2.80 235 177 58
192-216 625 90.0 2.57 231 183 48
LD., 52yewoldfemale, postopenrtiv.hypoporothyroldism. Coatinuousinfusion of bufferedsodIumphosphateiad ils.. 137-145min.,Praothyroidextract,(Lillyno.628857), 500 USPunits i.v.
lower B. C.'s plasma P and TmP without altering thelevel of plasma Ca. Hyperparathyroidism was
induced in this subject by intermittent intravenous administrationof extract. This wasthe only one
of the prolonged studies reported in hypopara-thyroidpatients in which PTHwasgiven by other
than the subcutaneous route. D. F. and W. R., two normal subjects, received three successive daily infusions, each containing 1,500 units of
extract, and each given intravenously over a
six-hour period. No effect on plasma Ca or P or on
TmP (measured 15 hours after the last infusion ofPTH) wasobserved. In W. R.,anequal
auan-tity ofthe same lot of hormone given in repeated
subcutaneous injections over a similarperiod
pro-duced marked hyperparathyroidism (Table VII).
DISCUSSION
Two explanations have been offered for the
in-crease in urinary phosphate usually observed
fol-lowing the administration of parathyroid extract. The evidence supporting these hypotheses, an in-crease in the load of phosphate filtered through
the kidney, on the onehand, and a diminution in
the tubular reabsorption of phosphate, on the
other,hasbeensummarized by Bartter (8). The 'The fall in CI3 in this subject in the hyperparathy-roid state was believed ascribable to mild congestive heart failure, a state known to be accompanied by a
reduced GFR (7). Digitalis, with which she had been treated for signs of failure noted one year previously,
had been omitted prior to the administration of
para-thyroidextract
rise in filtered phosphate has been ascribed to an
increase in glomerular filtration rate, to a rise
in plasma phosphate, orto both (9-11). Indeed, the demonstration that phosphaturia follows the administration to animals of formalin-inactivated (as assayed by its effect on serum calcium)
para-thyroid extract has been interpreted as indicating
that the observed increase in urinary phosphate is an artifact ascribable to some non-hormonal
componentofanexceedingly heterogeneous
prepa-ration (12).
Our data indicate that the phosphaturia seen
immediately following the intravenous adminis-tration of the extract to normal individuals is the result of an increase in GFR with a consequent
z 250
i
1200
z
0
1-CL .150
0
('
co 4
or
tW 100
W
I SO
4
CL))
aO
MINUTES
FIG. 4. CHANGES IN TMP FOLLOWING THE
ADMINIS-TRATION OF PARATHYROID EXTRACT TO THREE SUBJECTS
wrrt HYPoPARATHYROIDISm
IPARATHYROIDEXTRACT v.
_ ~~~~~~500U.S.P.
UNITS-SUBJECTS
I-o--NA.W.
o9---3oB.C.
90 60 30 0 30 s0 90 120
561
HOWARD H. HIATT AND DAVID D. THOMPSON
TABLE VI
ACUTE EFFECTS OF INTRAVENOUS PARATHYROID EXTRACT ON RENAL FUNCTION IN NYPOPARATHYROIDISM
Units CPAII CIN TaP
Doe Subject of Before After Percent Before After Percet 3.fee After rcenpt
Extract Mi/ala. ml/min. Chong*,emI/mim/mi. Chonge p/mi.. P.M/ai.. Champ
8/25/54 A.W. SOO 96 103 + 7 is1 142 -10 2/25/SS A.W. 500 498 852 + 71 108 113 + 5 137 75 -45
2/22/55 B.C. 500 230 418 + 75 63 69 + 10 SO - 49 3/9/55 L D. 500 325 668 + 102 75 87 + 16 Si -48
TABLE VII
EFFECTS OF PROLONGED ADMINISTRATION OF PARATHYROID EXTRACT ON PLASMA AND URINARY CALaWU AND PHOSPHORUS
Total Plosma Co Plsme P Urine Co Urine P
Subject Units of Hours of mg. percent MA/mI MM/Min. PAw.in.
Administration - -
-Extract Before After Before After Before After Befor Afbu
Notma_
C.H. 7/13/54 4000 60 9.80 13.50 1.23 1.02 9 52
W.R. 8/19/54 4500 72 10.02 13.90 0.96 0.73 23 s2
W.R. 5/ 6/55 4000 72 9.40 15.20 0.98 0.63 280 420 7 27
E.P. 3/31/55 2500 120 10.60 12.90 1.17 0.6 213 506 8 20
LB.11/22/54 2100 72 9.20 12.00 0.90 0.70 257 44 16 24
W.H 10/22/54 1800 66 .60 11.31 1.23 0.96 161 212 9 25
Hyporthyroid
A.W. 9/30/54 3000 % 7.10 12.90 1.42 06 3 9 0.9 11
B. C. 2/24/54 2500 60 LOS 11.95 1.35 0.74
TABLE VIII
RENAL EXCRETION OF PHOSPHATE BEFORE (A) AND AFTER (B)
ADMINISTRATION OF 1500 USP UNITS OF PARATHYROID EXTRACT DAILY FOR 3 DAYS
ELAPSED PHOSPHATE
TIME CPAH CIN PLASMA P FILTERED EXCRETED REABSORBED
Min. ml/min. ml/min. FM/ml. |SM/ri.. PM/min. PM/Min.
A 80- 109 570 100 2.43 243 104 139
109-139 580 102 2.74 279 143 136 139-169 555 106 3.05 324 181 143
B 183-222 684 124 2.36 29m 214 78
222-243 665 107 2.61 279 225 54
266-293 576 111 2.33 259 213 46
W.R.22 yearold normalmale.
Continuous infusion of buffered sodiumphosphateand vulii.
rise in filtered phosphate. In hypoparathyroid subjects the relative increase in phosphate
excre-tionis even more
striking,
for in such individualsparathyroid extract produces not only a rise in
filtration rate, but a depression of tubular
TABLE IX
RENAL EXCRETION OF
PHOPHATE
BEFORE (A) AND AFTER(B)
STRATICN OF
900
USP UNITS OFPARATHYROID
EXTRACT DNLY FOR 3 DAYSELAPSED _____PHOSPHATE
TE CPH CIN PLASMA P FILTERED EXCRETED REABSORBED Min. Mlmn ml min )L/M.L//I.A . I&M/mIn. ILM/min.
A 16 -205 86 865 265 229 60 169
205 -232 95 86.0 3.17 2n 98 174 26529692 82.5 4.36 360 188 172
B 165--1 206 131 1.77 232 163 69
228-256 218 133 2.35 312 267 45
256-286 212 129 3.07 396 295 101
A.W.,37ywoldhypoporul yroidmle.
Co"ti;u
as
infusionofhnuIi
mndbuffered sodiumphosphOte.
TABLE X
EFFECTS OF PROLONGED AMINISTRATION
taneous administration of extract, however, both
to normal and to hypoparathyroid subjects in-duces a state of hyperparathyroidism, character-ized by an invariable and striking diminution in
TmP. No effortwasmadetodetermine the mini-mal period of extract administration required be-foreatubular effect is demonstrable innormal
in-dividuals; sixty hours was the shortest duration
of an experiment involving the subcutaneous
ad-ministration of hormone, and a 31 per cent
de-crease in TmP was observed. Why the tubular
effect is more readily demonstrable in the
hypo-parathyroid than in the normal individual is
un-known, but this phenomenon may have a parallel
in the increased sensitivity to small amounts of thyroid noted in patients with myxedema (13). Of considerable interest is the fact that the
in-duced hyperparathyroid state in several of our
OF PARATHYROID EXTRACT ON RENAL FUNCTION
subjects wasnotaccompaniedbyarise in GFRor
inRPF. These observations strengthen the thesis that the factor in parathyroid extract exerting an
action on renal hemodynamics is distinct from
the hormonal principle(s) responsible for hyper-calcemia and a reduction in TmP. While our
data support the concept that the phosphaturia
seen in normal subjects immediately after the
in-travenous administration of PTH is not the result of changes in renal tubular transport of phosphate, they also demonstrate that under ap-.
propriate conditions tubular reabsorption of phos-phate is profoundly inhibited by the hormone. Similar findings have been noted in the dog by Handler and Cohn (14).
The fact that prolonged administration of the
extract is required to depress TmP in normal individuals raises the question as to whether the
Total
oCfACPAH
CIN TmPstki¢t o Before After Percent Before After Prcomi Befe Afer Peret
Ex|tracI Ml/min. ml/mill. Change mi /mi. Oange Al/Mwin. PMl/mie. Opche
C.H.7/13/54 4000 60 550 763 + 39 135 151 + 12 200 138 -31
W. . 8/19/54 4500 72 585 728 + 24 113 121 + 7 122 63
-4a
W R.S/ 6/55 4000 72 558 568 +2 102 95 -7 81 29 -i P.3/31/55 2500 120 537 430 -20 96 8s -11 110 64 -42 LB.11/22/54 2100 n 846 837 -1 136 131 -4 124 91 .27 W.K10/22/54 1800 46 904 889 -2 125 129 + 3 179 116 -3N A. W.9/30/54 200 n 157 200 + 96 129 +34 175n -59
LC 2/24/54 2SOO 60 236 232 -2 74 57 23 131 56 -57
HOWARD H. HIATT AND DAVID D. THOMPSON
TABLE XI
EFFECTS OF PARATHYRW
EUiRkf
SI YLPOPARATiYOiWSlA(BC.)_e. Elmt ElepsTd Plow _. Plasm
Ear
1.
.vwini..Fiberei_
Ex*Folisrid|E2/9/55
Wms.
0 * SX*t~ iCiem of W19*-wi,,PAN, id pGoo
89-121 6.85 -.40 3.33 252 5 252 114 138
121_153 .07 3.73 234 '73.6 274 143 131
IS3_
-M 1.81 i"<too 222 a 161 12SA.
237
1n
1 139 132 2/14/55 50m.Wld 0 7.56 0.91
X4w 3dep X6 h-ComismossI.~slem of Wim;'FIAN,
pb.bsIH
sad o,93_124 832 2.09 2.67 2" A*4.O 24 131 9
124-157
8821
94265 b
. 2441"
78157 -187 9.40 La W.3 _S .3 277 194 a
los. j 259 83.4 248 I 8s
2/24/55 MEOs.q. 0 111.95 L74t1
12bkeSi.. 10 C_stleessiAusim.ofIsili, PAN.sdpbospv
in-25 3.41 2.57 1220 57.7 n148 9 I
20 -2413
51AS
3.02 225 1 l1131
55241-270 OI 9.03 32
252_SjS 51"
_17 62___
___
I
it
123215.6
i1161
hormone acts directly on the renal tubule. That
the hypercalcemia produced by the hormone is notresponsibleforthechange in tubulartransport
ofP is indicated by the demonstration thata rise in plasma Ca leads to an increase in the tubular
reabsorption of P
(15).
In addition, thepromptand striking fall in TmP which follows the
intra-venous administration of
parathyroid
extract to
I-a
40
Is
0-0 100 200 300
PHOSPHATE FILTEREDAM/ MINUTE
400
FIG. 5. TUBULAR REABSORPTION OF PHOSPHATE AT
SEVERAL LvETs OF FITERED PHOSPHATE IN A
Hypo-PAATHYROID SUBJECTIN THE UNTREATED STATE, IN AN "ISOPARATHYROID" STATE, AND IN A HYPERPARATHYROID STATE
hypoparathyroid subjects strongly suggests a di-recteffectof the hormone on the renaltubule.
No manifestations of
hyperparathyroidism
wereobserved in W. R. following the intravenous ad-ministration of 1500 units of extract over a
six-hour period on each of three successive days.
Whether the renal tubule and bone of the normal
individual must be constantly exposed to the ex-tract for an even more prolonged period of time
before achangein TmP or in calcium metabolism is demonstrable remains to be answered.
The demonstration of an action of PTH on the
kidney does not, of course, exclude an effect on
bone. Indeed, only by invoking an action of the
hormone at both sites can one satisfactorily
ex-plain the chemical aberrations characteristic of
patients
with hyperparathyroidism. It would ap-pear reasonable, then, to assume that thesecre-tion(s)
of the parathyroid alters metabolic proc-esses in bone, in kidney, and possibly evenelse-where.
SUMMARY
1. The intravenous administration of parathy-roid extract results in aphosphate diuresis. Such
aneffect in normal subjects can generally be
ac-counted for by a rise in filtered phosphate
sec-ondary
toariseinglomerular
filtrationratewith-A.W. d' 37 YEARS
POST-OPERATIVEHYPOPARATHYROIDISM
* NoMEIArIe
o PARKiWOID EXTRACT100USPUNISS.C.00XS A * gm * C..DX
0 .
_ if ' ' o _~~
EFFECTS OF PARATHYROID ON RENAL FUNCTION
out any decreaseinphosphate Tm. In hypopara-thyroid individuals there is a diminution in the tubular reabsorption of phosphate as well as an
increase in filtered phosphate.
2. Repeated subcutaneous injections of para-thyroid extract both to normal and to
hypopara-thyroid individuals lead to a diminution in the
maximal tubular reabsorptive capacity for
phos-phate.
3. The phosphaturia seen after the acute
ad-ministration of extract to normal individuals is
usually caused by an action of the extract on re-nal hemodynamics and is not
accompanied
by
hy-percalcemia.Following
theprolonged
adminis-tration ofparathyroid extract to normal individu-als, however, hypercalcemia is observed as well as a decrease in TmP, but without any constant
change in renal
hemodynamics.
ACKNOWLEDGMENT
We wish to express our gratitude to Misses Mary Margaret Brown and Doris Graves for their technical assistance.
REFERENCES
1. Barnicot, N. A., The local action of the parathyroid and other tissues on bone in intracerebral grafts. J.Anat., 1948,82, 233.
2. Chang, H.-Y., Grafts of parathyroid and other tis-sues to bone. Anat. Record, 1951, 111, 23. 3. Grollman, A., The role of the kidney in the
para-thyroid control ofthe blood calcium as determined by studiesonthenephrectomizeddog. Endocrinol-ogy, 1954, 55, 166.
4. Greenwald, I., and Gross, J., The effect of the ad-ministration of a potent parathyroid extract upon
the excretion ofnitrogen, phosphorus, calcium,and magnesium, withsome remarksonthesolubility of calciumphosphatein serum andonthe pathogene-sis oftetany. J. Biol. Chem., 1925, 66,217. 5. Albright, F., Bauer, W., Ropes, M., and Aub, J. C.,
Studies of calcium and phosphorus metabolism. IV. The effect of the parathyroid hormone. J. Clin. Invest., 1929, 7, 139.
6. Thompson, D. D., and Hiatt, H. H., Renal reab-sorption of phosphate in normal human subjects and in patients with parathyroid disease. J. Clin. Invest., 1957, 36, 550.
7. Merrill, A. J.,and Cargill, W. H., The effect of
ex-ercise on the renal plasma flow and filtration rate of normal and cardiac subjects. J. Clin. Invest., 1948, 27,272.
8. Bartter, F.C.,The parathyroids. Ann. Rev. Physiol., 1954, 16, 429.
9. Jahan, I., and Pitts, R. F., Effect of parathyroid on
renal tubular reabsorption of phosphate and cal-cium. Am. J. Physiol., 1948, 155, 42.
10. Handler, P., DeMaria, W. J. A., and Cohn, D. V., Mode of action of parathormone. Federation Proc., 1949,8, 204.
11. Hogben, C. A. M., and Bollman, J. L., Renal reab-sorption of phosphate: normal and thyropara-thyroidectomized dog. Am. J. Physiol., 1951, 164, 670.
12. Stewart,G. S., andBowen, H. F., Theurinary
phos-phate excretion factor of parathyroid gland ex-tracts: A hormone or an artefact? Endocrinol-ogy, 1952, 51, 80.
13. Means, J. H.,TheThyroidand Its Diseases. 2nded., Philadelphia, J. B. Lippincott Co., 1948.
14. Handler, P., and Cohn, D. V., Effect of parathyroid extract on renal function. Am. J. Physiol., 1952, 169,188.
15. Hiatt, H. H.,and Thompson, D. D., Some effects of intravenously administered calcium on inorganic phosphate metabolism. J. Clin. Invest., 1957, 36, 573.
SPECIAL NOTICE TO
SUBSCRIBERS
Post Offices will nolonger forward the Journalwhen you move.
Please notify The Journal of Clinical Investigation, Business Office,622 West 168th Street, New York 32, N. Y. at once when youhave achangeofaddress, and do not omit the zone number if there is one.